Prof Rodney Baber AM

Drugs and devices, Obstetrics and gynaecology

Videos

Estradiol and dydrogesterone for post menopausal hormone replacement therapy

In this Product Explainer, Prof Rod Baber, Gynaecologist and Head of the Menopause and Menstrual Disorders Clinic at the Royal North Shore Hospital explains the role of estradiol and dydrogesterone post menopausal hormone therapy for women during menopause transition, as well as why and when to use it (6 mins).

Obstetrics and gynaecology, Women's health

Podcasts

Practical advice for transdermal & intravaginal MHT

Why is transdermal MHT the preferred option for most patients?

Obstetrics and gynaecology

Videos

Progesterone for postmenopausal women

In this Product Explainer, Prof Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at Sydney Medical School, University of Sydney and Head of the Menopause and Menstrual Disorders Clinic, Royal North Shore Hospital, explains when to use; how to use; and why to use progesterone for postmenopausal women. (6 mins)

Obstetrics and gynaecology

Videos

Estradiol Gel

In this Product Explainer, Professor Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at The University of Sydney discusses why estradiol gel should be used, how it is administered and when it should be prescribed and used (4 mins).

Obstetrics and gynaecology

Monographs

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney; Past President, International Menopause Society and Australasian Menopause Society

More from this expert

Estradiol and dydrogesterone for post menopausal hormone replacement therapy

Practical advice for transdermal & intravaginal MHT

Why is transdermal MHT the preferred option for most patients?

Progesterone for postmenopausal women

Estradiol Gel

In this Product Explainer, Professor Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at The University of Sydney discusses why estradiol gel should be used, how it is administered and when it should be prescribed and used (4 mins).

Micronised Progesterone and Its Relevance to the Management of the Menopause

This article discusses why some of the Women’s Health Initiative (WHI) Randomised Clinical Trial conclusions are now considered to be exaggerated.

Understand & explain the risks & side effects of MHT

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

Menopausal hormone therapy in patients at risk of cancer

Key considerations for assessing suitability, balancing benefits and risks, and individualising care...

Menopausal hormone therapy and its cardiovascular benefits

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Interpreting the FDA’s MHT decision: What clinicians should know

Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.

Navigating the realities of menopause care – Panel

Dr Jane Elliott AM, Dr Sonia Davison, Prof Rod Baber AM & Dr James Brown unpack the evidence, misconceptions and practical decision-making that shape real-world menopause and perimenopause care in Australian general practice.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Save 50% on all seminars. Hurry, sale ends Dec 31!

You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney; Past President, International Menopause Society and Australasian Menopause Society

More from this expert

Why is transdermal MHT the preferred option for most patients?

In this Product Explainer, Professor Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at The University of Sydney discusses why estradiol gel should be used, how it is administered and when it should be prescribed and used (4 mins).

This article discusses why some of the Women’s Health Initiative (WHI) Randomised Clinical Trial conclusions are now considered to be exaggerated.

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

Key considerations for assessing suitability, balancing benefits and risks, and individualising care...

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.

Dr Jane Elliott AM, Dr Sonia Davison, Prof Rod Baber AM & Dr James Brown unpack the evidence, misconceptions and practical decision-making that shape real-world menopause and perimenopause care in Australian general practice.

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Save 50% on all seminars. Hurry, sale ends Dec 31!

You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!